Vincent Chan

Vincent Chan is a Scientific Advisor at Multiply Labs. Vincent has also worked as an Assistant Professor, Bakar Endowed ImmunoX Chief Strategist, Senior Scientist & Senior Manager at the University of California, San Francisco for 6 years and 6 months.

Chan has been instrumental in securing the entry of pharmaceutical partners for cancer and autoimmunity into the Immunoprofiler Consortias. Vincent has also helped to launch the Autoimmunity Consortium with initial partner, Eli Lilly. Chan is in charge of the overall operations of the $100m+ ImmunoX program and reports directly to the Chairperson.

Chan's individual research efforts within the Immunoprofiler Cancer Consortium are focused on data discovery across colorectal cancer cases. These efforts are being translated into the assembly of a first-author publication towards a JCI/Cancer Cell or equivalent paper. With a $150K award from the Benioff Initiative for Prostate Cancer Research (BIPCR) and additional support from the Immunoprofiler Consortium, Chan plans to transition their research efforts towards immune class discovery in prostate cancer once the colorectal paper is completed and published.